Delgocitinib Cream Improves Chronic Hand Eczema in Second Phase 3 Trial
Positive results were announced from the DELTA 2 study evaluating delgocitinib cream in patients with moderate to severe chronic hand eczema.
Stay updated with breaking news from Global Research Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Positive results were announced from the DELTA 2 study evaluating delgocitinib cream in patients with moderate to severe chronic hand eczema.
Delgocitinib cream significantly improved chronic hand eczema in adult patients, according to topline results from the DELTA 1 study.
/PRNewswire/ -- Prologis, Inc. (NYSE: PLD), the global leader in logistics real estate, today hosted its annual GROUNDBREAKERS thought leadership forum...
Energy and Supply Chain Leaders Gathered for Prologis' GROUNDBREAKERS 2022 in NYCNEW YORK, Oct. 25, 2022 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD...
/PRNewswire/ -- Prologis, Inc. (NYSE: PLD), the global leader in logistics real estate, today hosted its annual GROUNDBREAKERS thought leadership forum...